What are the global trends in diabetes prevalence and treatment over the past three decades, and how do they compare across countries? A study published in The Lancet examines global diabetes trends from 1990 to 2022. This research highlights the alarming rise in diabetes prevalence and treatment gaps, emphasizing the urgent need for action.
The global rate of diabetes (combining type 1 and type 2) in adults has doubled from approximately 7% in 1990 to about 14% in 2022.
This increase has resulted in over 800 million adults living with diabetes worldwide, which is more than four times the number in 1990.
The largest increases in diabetes rates were observed in low- and middle-income countries (LMICs), where the disease burden has significantly risen. In contrast, regions like North America, Australasia, central and western Europe, and parts of Latin America and East Asia and the Pacific have seen improvements in diabetes treatment rates, contributing to widening global inequities in diabetes treatment.
Despite the increasing prevalence, treatment rates for diabetes have stagnated at low levels in many LMICs. As a result, nearly 450 million adults aged 30 and over with diabetes (approximately 59%) did not receive treatment in 2022.
The findings emphasize the urgent need for financing of medicines and comprehensive diabetes programs to enable early detection and effective treatment of diabetes, particularly in LMICs. Overall, the study underscores the growing global burden of diabetes, especially in low-income regions, and highlights the critical need for improved access to diabetes treatment and care.
🌍 *Could a twice-yearly shot revolutionize HIV prevention?*
Gilead Sciences has submitted key applications to the EMA for lenacapavir, a groundbreaking HIV-1 capsid inhibitor designed for use as pre-exposure prophylaxis (PrEP). With promising trial results indicating a significant reduction in HIV infections, this innovation could enhance adherence to prevention strategies globally. Discover more about this game-changing development!
#SyenzaNews #globalhealth #healthcareInnovation
🌍 Can collaboration redefine Africa’s health landscape?
A newly signed Memorandum of Understanding between Africa CDC and Global Health EDCTP3 promises to enhance health research, clinical trials, and pandemic preparedness on the continent. With a focus on training, local manufacturing, and equitable partnerships, this initiative aims to address pressing global health challenges while improving health outcomes across Africa.
Look into the details of this transformative partnership and its implications for the future of healthcare in the region!
#SyenzaNews #globalhealth #HealthcareInnovation
🚨 Are we doing enough to tackle the imminent breast cancer crisis in Africa?
A recent WHO report reveals alarming trends, predicting that 135,000 women could succumb to breast cancer by 2040 unless urgent actions are taken. The report highlights critical gaps in healthcare infrastructure and capacity, emphasizing the need for investment in screening programs and professional training to improve outcomes across the continent.
Review the full article to explore the necessary steps towards reinforcing breast cancer control measures in Africa.
#SyenzaNews #globalhealth #oncology #HealthTech
SPEAK WITH US
CORRESPONDENCE ADDRESS
1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA
WRITE US
JOIN NEWSLETTER
